US Patent 10221396 Reprogramming T cells and hematopoietic cells
Is a
Date Filed
April 26, 2017
Date of Patent
March 5, 2019
Patent Applicant
Patent Application Number
15498172
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10221396 Reprogramming T cells and hematopoietic cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.